Evaluation of the Use of Cyclophosphamide in Children Diagnosed with Steroid-Resistant Nephrotic Syndrome Treated at Fatmawati Hospital
December 2022
in “
Jurnal Farmasi Klinik Base Practice
”
Studysummary In this study of children with nephrotic syndrome treated with cyclophosphamide, 59.4% achieved remission, and 40.6% experienced side effects including nausea, vomiting, and hair loss.
Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer
Read the full study on rsupfatmawati.co.id →